Brief: Herantis Pharma Announces Successful Completion Of Six-Month Glp Toxicology Study Of Her-096
26/11/2025 12:02
Nov 26 (Reuters) - Herantis Pharma Oyj HRTIS.HE: HERANTIS PHARMA ANNOUNCES SUCCESSFUL COMPLETION OF SIX-MONTH GLP TOXICOLOGY STUDY OF HER-096 HERANTIS PHARMA OYJ - HER-096 RESULTS SUPPORT LONG-TERM ADMINISTRATION, PHASE 2 TRIAL MILESTONE Source text: ID:nGNXF65bC Further company coverage: HRTIS.HE ((Reuters.Briefs@thomsonreuters.com;))